Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value ($000): $1,050,041 (99.4% shares, 0.6% debt)

Holdings (22)

INGN INOGEN INC 22.7%

Value ($000) $238,408 Shares 3,549,320 Est. Cost $17.78 Unrealized +246.8%

VTI VANGUARD INDEX FDS 17.8%

Value ($000) $187,176 Shares 1,623,100 Est. Cost $57.39 Unrealized —

— COLUCID PHARMACEUTICALS INC 10.9%

Value ($000) $114,899 Shares 3,156,563 Est. Cost $9.83 Unrealized —

VGK VANGUARD INTL EQUITY INDEX F 9.6%

Value ($000) $100,722 Shares 2,101,000 Est. Cost $45.01 Unrealized —

— REATA PHARMACEUTICALS INC 7.0%

Value ($000) $73,518 Shares 3,367,763 Est. Cost $19.75 Unrealized —

IRTC IRHYTHM TECHNOLOGIES INC 5.8%

Value ($000) $60,733 Shares 2,024,448 Est. Cost $26.94 Unrealized 0.0%

CRVS CORVUS PHARMACEUTICALS INC 4.4%

Value ($000) $46,104 Shares 3,224,046 Est. Cost $14.33 Unrealized +6.1%

— ACCELERON PHARMA INC 3.0%

Value ($000) $31,649 Shares 1,240,173 Est. Cost $27.95 Unrealized —

— RA PHARMACEUTICALS INC 2.9%

Value ($000) $30,859 Shares 2,031,562 Est. Cost $15.19 Unrealized —

— MERUS N V 2.8%

Value ($000) $29,774 Shares 1,410,417 Est. Cost $7.99 Unrealized —

— SPECTRANETICS CORP 2.8%

Value ($000) $28,889 Shares 1,179,122 Est. Cost $18.19 Unrealized —

— FLEXION THERAPEUTICS INC 2.5%

Value ($000) $26,585 Shares 1,397,718 Est. Cost $16.32 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 2.0%

Value ($000) $20,517 Shares 2,901,927 Est. Cost $7.37 Unrealized 0.0%

— APOLLO ENDOSURGERY INC 1.7%

Value ($000) $17,716 Shares 1,456,972 Est. Cost $12.16 Unrealized —

— NABRIVA THERAPEUTICS AG 1.3%

Value ($000) $13,866 Shares 2,326,544 Est. Cost $7.44 Unrealized —

— INVUITY INC 0.7%

Value ($000) $7,581 Shares 1,318,448 Est. Cost $9.58 Unrealized —

— DERMIRA INC 0.6%

Value ($000) $6,568 Shares 216,562 Est. Cost $30.33 Unrealized —

— WRIGHT MED GROUP N V 0.6%

Value ($000) $6,101 Shares 4,622,032 Est. Cost $1.25 Unrealized —

CRSP CRISPR THERAPEUTICS AG 0.4%

Value ($000) $4,524 Shares 223,317 Est. Cost $18.69 Unrealized 0.0%

— HTG MOLECULAR DIAGNOSTICS INC 0.3%

Value ($000) $2,868 Shares 1,280,185 Est. Cost $11.15 Unrealized —

XENE XENON PHARMACEUTICALS INC 0.1%

Value ($000) $982 Shares 127,563 Est. Cost $14.68 Unrealized -45.3%

OPK OPKO HEALTH INC 0.0%

Value ($000) $2 Shares 259 Est. Cost $9.96 Unrealized +3.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
INGN	INOGEN INC	3,549,320	$238,408	22.7%	$17.78	+246.8%	COM	45780L104
VTI	VANGUARD INDEX FDS	1,623,100	$187,176	17.8%	$57.39	—	TOTAL STK MKT	922908769
—	COLUCID PHARMACEUTICALS INC	3,156,563	$114,899	10.9%	$9.83	—	COM	19716T101
VGK	VANGUARD INTL EQUITY INDEX F	2,101,000	$100,722	9.6%	$45.01	—	FTSE EUROPE ETF	922042874
—	REATA PHARMACEUTICALS INC	3,367,763	$73,518	7.0%	$19.75	—	CL A	75615P103
IRTC	IRHYTHM TECHNOLOGIES INC	2,024,448	$60,733	5.8%	$26.94	0.0%	COM	450056106
CRVS	CORVUS PHARMACEUTICALS INC	3,224,046	$46,104	4.4%	$14.33	+6.1%	COM	221015100
—	ACCELERON PHARMA INC	1,240,173	$31,649	3.0%	$27.95	—	COM	00434H108
—	RA PHARMACEUTICALS INC	2,031,562	$30,859	2.9%	$15.19	—	COM	74933V108
—	MERUS N V	1,410,417	$29,774	2.8%	$7.99	—	COM	N5749R100
—	SPECTRANETICS CORP	1,179,122	$28,889	2.8%	$18.19	—	COM	84760C107
—	FLEXION THERAPEUTICS INC	1,397,718	$26,585	2.5%	$16.32	—	COM	33938J106
KALV	KALVISTA PHARMACEUTICALS INC	2,901,927	$20,517	2.0%	$7.37	0.0%	COM	483497103
—	APOLLO ENDOSURGERY INC	1,456,972	$17,716	1.7%	$12.16	—	COM	03767D108
—	NABRIVA THERAPEUTICS AG	2,326,544	$13,866	1.3%	$7.44	—	COM	62957M104
—	INVUITY INC	1,318,448	$7,581	0.7%	$9.58	—	COM	46187J205
—	DERMIRA INC	216,562	$6,568	0.6%	$30.33	—	COM	24983L104
—	WRIGHT MED GROUP N V	4,622,032	$6,101	0.6%	$1.25	—	RIGHT 03/01/2019	N96617126
CRSP	CRISPR THERAPEUTICS AG	223,317	$4,524	0.4%	$18.69	0.0%	NAMEN AKT	H17182108
—	HTG MOLECULAR DIAGNOSTICS INC	1,280,185	$2,868	0.3%	$11.15	—	COM	40434H104
XENE	XENON PHARMACEUTICALS INC	127,563	$982	0.1%	$14.68	-45.3%	COM	98420N105
OPK	OPKO HEALTH INC	259	$2	0.0%	$9.96	+3.9%	COM	68375N103